Discuss recent guideline-directed and pharmacologic updates in the management of cardiovascular disease, including hypertension, lipids, acute coronary syndrome, and heart failure.
Evaluate emerging concepts in holistic cardiovascular care, including the gut microbiome and other nontraditional risk modifiers.
Integrate cardiovascular guideline updates and holistic care innovations to formulate evidence-based, patient-centered treatment plans in diverse clinical scenarios, including transitions of care and high-risk populations.